Climb Bio (CLYM) announced the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Before joining Climb Bio, Dr. Wilson served as ...
Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson ...
马萨诸塞州韦尔斯利希尔斯讯 - 市值1.02亿美元的临床阶段生物科技公司Climb Bio, Inc. (NASDAQ: CLYM )宣布任命Perrin Wilson博士为新任首席商务官。Wilson博士在制药和生物科技行业拥有超过17年的经验,将加入公司管理团队,负责领导商业化前期规划、沟通和业务发展工作。
Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson is an accomplished ...
In a challenging market environment, shares of Eliem Therapeutics, Inc. (CLYM) have reached a 52-week low, dipping to $1.5. According to InvestingPro data, the company maintains a strong financial ...
在充满挑战的市场环境下,Eliem Therapeutics, Inc. (CLYM)的股价已触及52周新低,跌至1.5美元。根据InvestingPro数据显示,该公司保持着稳健的财务状况,流动比率为57.7,资产负债表上现金多于债务。这家专注于开发神经系统疾病治疗方案的生物制药公司,其股价在过去一年中已从高位大幅回落。投资者目睹了公司市值的显著下降,过去六个月股价暴跌74%,目前市值为1.04 ...
KNE.V Kane Biotech Inc.
After hours: January 30 at 4:01:59 p.m. EST ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果